There are 2137 resources available
641P - Real-world patterns of genomic testing in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Neal Shore
Session: E-Poster Display
Resources:
Abstract
642P - Role of free testosterone serum levels during salvage chemotherapy with carboplatin plus weekly docetaxel in patients with docetaxel-refractory, metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Christoph Reuter
Session: E-Poster Display
Resources:
Abstract
643P - Evaluating biomarkers in metastatic castration resistant prostate cancer (mCRPC) patients (Pts) treated with enzalutamide (Enza): PSA, circulating tumor cell (CTC) counts, AR-V7 status, PET imaging vs. CT & Tc99 scans
Presenter: Shruti Gandhy
Session: E-Poster Display
Resources:
Abstract
644P - BRCA2 status and intraductal [IDC] and cribriform [CRIB] histologic variants: Partners in prostate cancer (PC)?
Presenter: Nuria Romero Laorden
Session: E-Poster Display
Resources:
Abstract
645P - Prediction of BRCA2 mutations in prostate cancer patients according early onset, metastatic phenotypes or family history of breast/ovary cancer
Presenter: Geraldine Cancel-Tassin
Session: E-Poster Display
Resources:
Abstract
646P - Prostate cancer metastatic profiles correlate with molecular alterations
Presenter: Olivier Cussenot
Session: E-Poster Display
Resources:
Abstract
647P - Clinical implications of intraductal carcinoma of the prostate sub-patterns in metastatic castration-resistant prostate cancer patients treated with abiraterone or docetaxel as the first-line therapy
Presenter: Wang Zhipeng
Session: E-Poster Display
Resources:
Abstract
648P - Abiraterone and dexamethasone in castration-resistant prostate cancer: Biological response after switch or rechallenge
Presenter: Mathieu Jamelot
Session: E-Poster Display
Resources:
Abstract
649P - Abiraterone acetate in men with metastatic castration-resistant prostate cancer and no prior chemotherapy: A double-arm, multiple-centre, phase III clinical study
Presenter: Zhiquan Hu
Session: E-Poster Display
Resources:
Abstract
650P - Comparing the predictive value of exosome, circulating tumor cells, and tumor tissue in detecting AR-V7 among metastatic castration-resistant prostate cancer treated with abiraterone
Presenter: Sha Zhu
Session: E-Poster Display
Resources:
Abstract